| MEDINCELL S.A. EO-,01 |
| Frankreich |
| Gesundheit |
| FR0004065605 / A2N6VA |
| MEB (Frankfurt) |
| FRA:MEB, ETR:MEB, MEB:GR |
| - |
| https://www.medincell.com.. |
|
MedinCell S.A. is a clinical-stage biopharmaceutical company specializing in the development of long-acting injectable therapies to improve treatment adherence and accessibility worldwide. Leveraging ..
>Volltext.. |
| 799.72 Mio. EUR |
| 804.48 Mio. EUR |
| 28.29 Mio. EUR |
| -11.79 Mio. EUR |
| -19.86 Mio. EUR |
| -0.61 EUR |
| 58.02 Mio. EUR |
| 19.39 Mio. EUR |
| -17.03 Mio. EUR |
| 2.51 |
| 166.31% |
| 36.57% |
| - |
| - |
| - |
| - |
| MEDINCELL |
| 21.02.26 |
|
||||
|